Home  /  Resource Library  /  Clinical efficacy of mogamulizumab for relapsed/refractory aggressive adult T-cell leukemia/lymphoma: A retrospective analysis

Clinical efficacy of mogamulizumab for relapsed/refractory aggressive adult T-cell leukemia/lymphoma: A retrospective analysis

Results of a retrospective study examining the effectiveness of Mogamulizumab for treatment of relapsed adult t-cell lymphoma. (Abstract only)